APO-Mometasone nasal spray: Two lots recalled due to possible risk of infection
Is your product affected? Check the DIN and lot number on your package against the list in Health Canada's official notice.
See affected DINs and lot numbers on Health Canada ↗Why it was recalled
Contamination
What you should do
- Do not use the affected product. Return it to your local pharmacy for proper disposal.
- Seek medical attention if you or your child have used this product and are experiencing persistent or worsening symptoms, such as fevers, or facial pain or pressure. Consult a health care professional if you or your child have used this product and have health concerns.
- Contact Apotex Inc. Customer Service by calling 1-877-427-6839 if you have questions about this recall.
- Report any health product-related side effects or complaints to Health Canada.
Other Recent Recalls
PegLyte Powder
PegLyte Powder: Affected lots may contain foreign matter
Type III2026-11-17
Low health risk
Taro-Candesartan tablets
TARO-CANDESARTAN: affected lots may contain Esomeprazole 20mg capsules
Type II2026-11-16
Moderate health risk
SECARIS NASAL GEL
SECARIS NASAL GEL: Affected lot may contain foreign matter
Type II2026-11-13
Moderate health risk
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.